SCHEMBL4928440

SCHEMBL4928440

CC(C)Nc1cc(F)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 1/20 0.39
HSD17B10 Q99714 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
ABL1 P00519 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RIN1 Q13671 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PLAU P00749 2/20 0.35
GCGR P47871 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717901 0.95 GPR139 (0.36) GPR139HSD17B10ALDH1A1GAAKDM4E
SCHEMBL5105172 0.89 BRD4 (0.39) GPR139ALDH1A1GAAKDM4EMEN1
SCHEMBL4930828 0.89 SMN1; SMN2 (0.39) GPR139MEN1RAB9AKMT2ALMNA
SCHEMBL4934497 0.89 HSD17B10 (0.39) GPR139HSD17B10ALDH1A1GAAKDM4E
SCHEMBL4932562 0.89 ALDH1A1 (0.39) GPR139HSD17B10ALDH1A1GAAKDM4E
SCHEMBL5110128 0.89 SENP5 (0.40) GPR139HSD17B10ALDH1A1GAAKDM4E
SCHEMBL4924012 0.88 HSD17B10 (0.38) HSD17B10ALDH1A1GAAKDM4EMEN1
SCHEMBL5717927 0.87 THRA (0.45)
SCHEMBL4931811 0.87 THRA (0.40) HSD17B10ALDH1A1GAAKDM4EMEN1
SCHEMBL4923555 0.87 MRGPRX4 (0.41) MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA GPR139 184/4885HSD17B10 1738/4885ALDH1A1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.